Paclitaxel-eluting Balloon Angioplasty With Provisional Use of Nitinol Stent Versus Systematic Implantation of Paclitaxel-eluting Stent for the Treatment of Femoropopliteal de Novo Lesions

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 250 participants.

Also called NCT01969630

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 250 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01969630
Other papers using this trial's data
  • Drug-Eluting Balloon Versus Drug-Eluting Stent for Complex Femoropopliteal Arterial Lesions: The DRASTICO Study Journal of the American College of Cardiology, 2019-07-16 DOI, PubMed 31296293

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
Not reported
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01969630. Randomized; single masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2015-10 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Paclitaxel-eluting Balloon Angioplasty With Provisional Use of Nitinol Stent Versus Systematic Implantation of Paclitaxel-eluting Stent for the Treatment of Femoropopliteal de Novo Lesions
Condition
Peripheral Artery Disease
Intervention (Device)
PEB
Intervention (Device)
PES
Lead sponsor
Ospedale San Donato (class: other)

Record details

Record id
cardio:ct-nct01969630
Content hash
e4139207635dff5ed11535c302cd6cd040de5afdf0644f0adc8c47b9aaff807a